Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
INVENTIV HEALTH INC (VTIV)
|
Add to portfolio |
|
|
|
| Price: |
$26.06
| | Metrics |
| OS: |
1
|
k
| |
|
|
| Market cap: |
$26.1
|
k
| |
-38
|
% ROIC
|
|
Net debt:
|
$2.1
|
B
| |
7.1
|
x Debt/EBITDA
|
|
EV:
|
$2.1
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$294
|
M
| |
7.1
|
x EV/EBITDA
|
|
EBIT
|
$202
|
M
| |
10.4
|
x EV/EBIT
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
| Revenues | 2,321.3 | 2,073.2 | 1,904.5 | 1,072.0 | 1,119.8 | 977.3 | 766.2 | 556.3 |
| Revenue growth | 12.0% | 8.9% | | -4.3% | 14.6% | 27.5% | 37.7% | 58.0% |
| Cost of goods sold | 1,653.7 | 1,470.4 | 1,344.7 | 729.6 | 772.4 | 681.6 | 410.2 | 327.6 |
| Gross profit | 667.5 | 602.8 | 559.8 | 342.3 | 347.4 | 295.7 | 356.1 | 228.7 |
| Gross margin | 28.8% | 29.1% | 29.4% | 31.9% | 31.0% | 30.3% | 46.5% | 41.1% |
| Selling, general and administrative | 525.2 | 529.4 | 538.3 | 241.8 | 241.7 | 200.9 | 141.4 | 79.3 |
| EBITA | 191.8 | 143.9 | 112.9 | 112.9 | 120.7 | 106.3 | 83.8 | 62.0 |
| EBITA margin | 8.3% | 6.9% | 5.9% | 10.5% | 10.8% | 10.9% | 10.9% | 11.1% |
| Amortization of intangibles | 47.6 | 66.7 | 72.2 | 12.4 | 15.1 | 10.9 | 5.6 | 1.9 |
| EBIT | 144.3 | 77.2 | 40.7 | 100.5 | 105.6 | 95.4 | 78.2 | 60.1 |
| EBIT margin | 6.2% | 3.7% | 2.1% | 9.4% | 9.4% | 9.8% | 10.2% | 10.8% |
| Pre-tax income | -143.7 | -177.7 | -213.2 | 77.6 | -185.7 | 77.7 | 30.0 | 28.9 |
| Income taxes | -5.6 | -2.5 | -3.0 | 29.9 | -58.2 | 29.4 | -19.2 | -14.2 |
| Tax rate | 3.9% | 1.4% | 1.4% | 38.5% | 31.3% | 37.8% | | |
| Earnings from continuing ops | -151.5 | -181.5 | -217.3 | -0.8 | -1.1 | -1.1 | 49.2 | 43.1 |
| Earnings from discontinued ops | | -8.2 | -20.2 | 47.7 | -126.9 | 48.6 | | 43.9 |
| Net income | -151.5 | -189.6 | -237.6 | 46.9 | -128.0 | 47.5 | 51.2 | 86.9 |
| Net margin | -6.5% | -9.1% | -12.5% | 4.4% | -11.4% | 4.9% | 6.7% | 15.6% |
| |
| Diluted EPS | | | | ($0.02) | ($0.03) | ($0.03) | $1.64 | $1.53 |
| Shares outstanding (diluted) | | | | 33.8 | 33.0 | 32.3 | 30.1 | 28.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|